CD34 and osteopetrosis: In our previous studies, we have provided proof of concept for an autologous approach to treating osteopetrosis by hematopoietic stem cell-targeted gene therapy with clinically applicable lentiviral vectors in IMO patient CD34+ peripheral blood cells [23] and in the oc/oc osteopetrotic mouse model [9].